How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?

2016/12/15 by Danijela Leković, Danijela Lekovic, Predrag Miljic +4 · 1 citation
Medicine · #Gynecology #Hormonal and reproductive studies #Hormone #Hormone replacement #Hormone replacement therapy (female-to-male) #Intensive care medicine #Internal medicine #Medicine #Menopause #Menopause: Health Impacts and Treatments #Ovarian function and disorders #Postmenopausal women #Quality of life (healthcare) #Surgery #Thrombosis #Vasomotor #Venous thromboembolism

paper · doi:10.1016/j.blre.2016.12.001

openalex publication_date 2016/12/15 · crossref created 2016/12/15 · crossref issued 2017/05/01 · crossref published 2017/05/01 · crossref published-print 2017/05/01 · crossref deposited 2023/08/21 · openalex created_date 2025/10/10 · crossref indexed 2026/05/16 · openalex updated_date 2026/07/29

Citations

• The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy
• Esterified Estrogens and Conjugated Equine Estrogens and the Risk of Venous Thrombosis
• Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis
• Mechanisms of Estrogen-Induced Venous Thromboembolism
• The epidemiology of venous thromboembolism
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
• Bioidentical Hormone Therapy

Cited by

• Estrogen (medication) [wikipedia]